Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis
- PMID: 7632061
Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis
Abstract
Background and design: The concurrent finding of neurofibromatosis type 1 (NF), juvenile chronic myelogenous leukemia (JCML), and juvenile xanthogranuloma (JXG) has been repeatedly reported. Juvenile chronic myelogenous leukemia has been found more frequently in patients with NF and may present with various cutaneous manifestations, including JXG. To our knowledge, the relationship among these three entities has never been explored. The purpose of the present study is to explore this relationship by using a systematic review of the literature. We present five demonstrative cases of various associations among NF, JCML, and JXG.
Results: A family history of NF was found in 85% to 95% of children with NF and JCML (with or without JXG), as compared with that found in 47% of children with NF and JXG. The observed frequency of the triple association is 30-fold to 40-fold higher than that expected. It is estimated that children with NF and JXG have a 20-fold to 32-fold higher risk for JCML than do patients with NF who do not have JXG.
Conclusions: A concomitant finding of JCML and JXG in children with NF represents a true association, rather than a coincidence. A finding of JXG in an infant with NF should alert a physician to a possible development of JCML.
Comment in
-
Juvenile xanthogranuloma, neurofibromatosis 1, and juvenile chronic myeloid leukemia.Arch Dermatol. 1996 Nov;132(11):1390-1. doi: 10.1001/archderm.132.11.1390. Arch Dermatol. 1996. PMID: 8915325 No abstract available.
Similar articles
-
Association of juvenile xanthogranuloma with juvenile myeloid leukemia.Arch Dermatol. 1984 Mar;120(3):371-5. Arch Dermatol. 1984. PMID: 6422862
-
The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study.J Am Acad Dermatol. 2017 Jun;76(6):1084-1087. doi: 10.1016/j.jaad.2016.12.012. Epub 2017 Feb 8. J Am Acad Dermatol. 2017. PMID: 28189268
-
Iris juvenile xanthogranuloma in an infant - spontaneous hyphema and secondary glaucoma.Rom J Ophthalmol. 2017 Jul-Sep;61(3):229-236. doi: 10.22336/rjo.2017.41. Rom J Ophthalmol. 2017. PMID: 29450403 Free PMC article. Review.
-
Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia.Arch Dermatol. 1996 Jun;132(6):712-3. Arch Dermatol. 1996. PMID: 8651728 No abstract available.
-
[Hereditary hematopoietic malignancy with emphasis of juvenile chronic myelogenous leukemia and 7 monosomy syndrome].Nihon Rinsho. 1995 Nov;53(11):2737-41. Nihon Rinsho. 1995. PMID: 8538036 Review. Japanese.
Cited by
-
Juvenile xanthogranuloma: case report and review of the literature.Can J Plast Surg. 2008 Fall;16(3):175-7. doi: 10.1177/229255030801600309. Can J Plast Surg. 2008. PMID: 19721800 Free PMC article.
-
A Multifaceted Approach to Treatment of Recalcitrant Cutaneous Periorbital Juvenile Xanthogranuloma.J Ophthalmic Vis Res. 2023 Feb 21;18(1):130-134. doi: 10.18502/jovr.v18i1.12733. eCollection 2023 Jan-Mar. J Ophthalmic Vis Res. 2023. PMID: 36937193 Free PMC article.
-
Neurofibromatosis type 1 and associated malignancies.Curr Neurol Neurosci Rep. 2009 May;9(3):247-53. doi: 10.1007/s11910-009-0036-3. Curr Neurol Neurosci Rep. 2009. PMID: 19348714 Review.
-
Pediatric Neoplasms Presenting with Monocytosis.Curr Hematol Malig Rep. 2021 Jun;16(3):235-246. doi: 10.1007/s11899-021-00611-x. Epub 2021 Feb 25. Curr Hematol Malig Rep. 2021. PMID: 33630234 Review.
-
Neurofibromatosis type 1.J Am Acad Dermatol. 2009 Jul;61(1):1-14; quiz 15-6. doi: 10.1016/j.jaad.2008.12.051. J Am Acad Dermatol. 2009. PMID: 19539839 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials